Science & News
At Lo.Li. Pharma International, every step forward tells a story.
We believe that progress gains meaning when it’s shared, that’s why we open the door to the moments, insights, and milestones that build our journey.
From scientific advances to global events, from partnerships to everyday collaboration, this is where our path takes shape.
Science
GDM and Myo-inositol: state of art
Gestational diabetes mellitus (GDM) is a metabolic disorder characterised by an impaired glucose tolerance with onset or first recognition during pregnancy, which is characterized by
Ulipristal acetate in the treatment of Uterine Fibroids: EMA restrictions of use.
Uterine Fibroids and Ulipristal Acetate Uterine fibroids are benign tumours consisting of smooth muscle cells and connective tissues that grow within the uterine wall and
Quality of women’s life and polycystic ovary syndrome (PCOS)
Polycystic ovary syndrome (PCOS) is characterised by enlarged ovaries, multiple ovarian cysts and endocrinological and metabolic changes (hyperandrogenism, insulin resistance and consequent hyperinsulinemia). Among women
News
CPHI Barcelona 2023
We’re delighted to announce that our company will be making a notable appearance at the CPHI Barcelona 2023 Exhibition, taking place from the 24th to
Audits during Covid-19 pandemia: Remote Inspection
The Covid-19 epidemic, defined by the WHO as a public health emergency of international importance, and the subsequent declaration of a pandemic have brought considerable